Exhibit 99.1 Bioventus Reports First Quarter Financial Results • Raises Full-Year 2024 Financial Guidance Reflecting Enhanced Revenue Growth and Strong Execution of Strategic Priorities • Accelerated First Quarter Revenue Growth by 8.7%, Organic Growth* by 15.3% • Gross Margin Expanded 620 bps and Adjusted Gross Margin* 190 bps DURHAM, NC – May 7, 2024 – Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or the "Company"), a global leader in innovations for active healing, today reported financial results for the th ...